nhlbi-logo-new.png

Development of a Microfluidic Platform for Blood Testing in Neonatal and Pediatric Patients STTR (R41) - RFA-HL-14-025

This FOA encourages applications to develop microfluidic devices to analyze blood for factors related to the thrombotic, transfusion, and/or hemostatic status of pediatric/neonatal patients. Platforms should support clinical and/or research applications. Microfluidic designs that are multifunctional, with the capacity to perform multiple assays on a single blood sample, are of interest. Use of these devices could significantly reduce levels of phlebotomy-induced blood loss in pediatric/neonatal patients.

Development of a Microfluidic Platform for Blood Testing in Neonatal and Pediatric Patients SBIR (R43/R44) - RFA-HL-14-026

This FOA encourages applications to develop microfluidic devices to analyze blood for factors related to the thrombotic, transfusion, and/or hemostatic status of pediatric/neonatal patients. Platforms should support clinical and/or research applications. Microfluidic designs that are multifunctional, with the capacity to perform multiple assays on a single blood sample, are of interest. Use of these devices could significantly reduce levels of phlebotomy-induced blood loss in pediatric/neonatal patients.